Golden State Equity Partners’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$281K Buy
+758
New +$268K 0.02% 686
2026
Q2
– Sell
-34
Closed -$8.52K – 1759
2026
Q1
$8.52K Buy
+34
New +$8.46K ﹤0.01% 1349
2024
Q4
– Sell
-105
Closed -$31.5K – 893
2024
Q3
$31.5K Sell
105
-1,130
-91% -$346K ﹤0.01% 598
2024
Q2
$407K Buy
+1,235
New +$436K 0.08% 260

Other funds holding WST

Golden State Equity Partners's WST Position: Q3 2026 in Review

Golden State Equity Partners opened a new position in West Pharmaceutical (WST) in Q3 2026: 758 shares worth $281K. The stake represents 0.02% of the portfolio and ranks #686 among its holdings. This is a return to the name: Golden State Equity Partners previously reported a position in WST as recently as Q1 2026.

Golden State Equity Partners first reported a position in WST in Q2 2024 and has held it in 4 quarters since. The position peaked at $407K in Q2 2024. 881 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Golden State Equity Partners held 758 shares of West Pharmaceutical worth $281K as of Q3 2026.
  • West Pharmaceutical was a new Golden State Equity Partners position in Q3 2026.
  • West Pharmaceutical made up 0.02% of Golden State Equity Partners's portfolio in Q3 2026, its #686 holding.
  • Golden State Equity Partners first reported a position in West Pharmaceutical in Q2 2024 and has held it in 4 quarters since.
  • Golden State Equity Partners's West Pharmaceutical position peaked at $407K in Q2 2024.
  • 881 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Golden State Equity Partners's 13F filing for Q3 2026, filed 3 Nov 2026.